These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19647194)
21. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer]. Girard N; Mornex F Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220 [TBL] [Abstract][Full Text] [Related]
22. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407 [TBL] [Abstract][Full Text] [Related]
23. Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer. Edelman MJ; Burrows W; Krasna MJ; Bedor M; Smith R; Suntharalingam M Lung Cancer; 2010 Apr; 68(1):84-8. PubMed ID: 19540615 [TBL] [Abstract][Full Text] [Related]
24. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy]. Watanabe Y Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413 [TBL] [Abstract][Full Text] [Related]
25. Cure- or care-oriented regimen for stage III non-small-cell lung cancer? Hotta K; Nagio T; Matsuo K; Kiura K J Clin Oncol; 2011 Apr; 29(11):e320. PubMed ID: 21402605 [No Abstract] [Full Text] [Related]
26. Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike. Barton MK CA Cancer J Clin; 2012; 62(5):279-80. PubMed ID: 22847502 [No Abstract] [Full Text] [Related]
27. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
28. Combined modality therapy for stage III non-small-cell lung cancer. Anderson CS; Curran WJ Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of lung cancer]. Tomita M Gan No Rinsho; 1989 Jan; Spec No():128-37. PubMed ID: 2536852 [No Abstract] [Full Text] [Related]
30. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand. Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558 [TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant therapy of stage III non-small cell lung cancer]. Hara N; Ohta M Kyobu Geka; 1991 Dec; 44(13):1114-20. PubMed ID: 1661792 [TBL] [Abstract][Full Text] [Related]
32. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial. Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477 [TBL] [Abstract][Full Text] [Related]
34. Survival after surgery following chemotherapy for non-small-cell lung cancer. Molnár TF; Balikó Z; Sárosi V; Horváth PO Asian Cardiovasc Thorac Ann; 2010 Feb; 18(2):141-6. PubMed ID: 20304848 [TBL] [Abstract][Full Text] [Related]
35. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759 [TBL] [Abstract][Full Text] [Related]
36. Role of surgery following induction therapy for stage III non-small cell lung cancer. Daly BD; Cerfolio RJ; Krasna MJ Surg Oncol Clin N Am; 2011 Oct; 20(4):721-32. PubMed ID: 21986268 [TBL] [Abstract][Full Text] [Related]
37. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789 [TBL] [Abstract][Full Text] [Related]
38. [Therapy in non-small-cell lung carcinoma (NSCLC) in local advanced stage (inoperable IIIA/IIIB)]. Baumann M; Dienemann HC; Fietkau R; Rübe C; Thomas M Onkologie; 2006 Sep; 29 Suppl 2():11-4. PubMed ID: 16974122 [No Abstract] [Full Text] [Related]
39. [Advanced non-small-cell lung cancer: new effective therapeutic alternatives for tomorrow?]. Pérol M Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S20-7. PubMed ID: 15211228 [No Abstract] [Full Text] [Related]
40. Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection. Kappers I; van Sandick JW; Burgers JA; Belderbos JS; Wouters MW; van Zandwijk N; Klomp HM Eur J Cardiothorac Surg; 2009 Oct; 36(4):741-6. PubMed ID: 19699647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]